Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed

BOZEN, Italy - Health Robotics today announced that National Taiwan University Hospital (NTUH) has purchased and agreed to immediately install its flagship CytoCare Robot during 2009. Separately, it also announced that it has signed an exclusive 3-year distribution, licensing, and support contract with Pinnaclemed [a Double Success Co. Ltd. subsidiary]. Both NTUH and Pinnaclemed desire to safely, accurately, and cost-effectively automate the preparation of hazardous Oncology I.V. Admixtures with Health Robotics’ CytoCare Robot in Taiwan.

“We are very excited to install CytoCare at one of the most prestigious Asian institutions such as NTUH, well known for its commitment for the First in Asia Program, a well respected quality standard. After Malaysia, Australia, and Japan, NTUH will represent CytoCare’s fourth country installation in Asia/Pacific, a number that we expect to double over the next six months with successful ongoing activities in Singapore, Indonesia, Vietnam, China, India, and New Zealand,” stated Werner Rainer, Health Robotics’ CEO.

Health Robotics and National Taiwan University Hospital started Cytocare discussions over 2 years ago and embarked on a journey to satisfy NTUH’s country-specific needs in reference to the automation of Hazardous IV Admixtures. After extensive due diligence and 2009 budget approval, NTUH’s Oncology Pharmacy Director Ms. Joyce Chen and Health Robotics’ General Counsel Mr. Gaspar DeViedma formalized an agreement last week, including the quick installation of CytoCare at NTUH in October-November 2009. Subsequently, Health Robotics selected Double Success as its exclusive CytoCare partner in Taiwan and executed an agreement for the next 3 years, including both companies’ cooperation in the CytoCare installation and technical support for NTUH.

“We are delighted to have been chosen by Health Robotics as their exclusive CytoCare partner in our core market of Taiwan. CytoCare, the only existing Oncology IV Admixtures Robot in the world, represents an ideal complement to Double Success medical portfolio of products and services, including Intuitive Surgical’s daVinci Surgery Robot. We are very impressed that a small foreign company like Health Robotics could accomplish what they did at NTUH on their own, including the budget approval, a feat unheard of in Taiwan for a foreign company. It is indeed a testament to CytoCare’s features, benefits, and customer testimonials from all over the world that made the NTUH’s contract possible. We look forward to take the “baton” from Health Robotics and continue their work in our country, expanding the reach of CytoCare to other hospitals in Taiwan,” stated Eddy Liu, General Manager of Double Success Co., Ltd.

About National Taiwan University Hospital (NTUH):

NTUH started operations in 1895. NTUH’s modern hospital was designed to support the concept of “patient-centered-care”, by which treatment is delivered at the bedside whenever possible. The hospital endeavors to provide appropriate, effective, and compassionate care that is accessible, affordable, and culturally sensitive, and in all these respects it serves as a model to emulate for other hospitals and clinics across the nation. With more than 4,000 employees serving approximately 2,000 inpatient beds, 7,000 daily outpatients visits, and over 200 chemotherapy treatments per day, NTUH remains the best-known and highest-quality academic medical center in Taiwan. For more information, please visit www.ntuh.gov.tw/en/default.aspx

About Health Robotics:

Health Robotics is the global leading supplier of life-critical intra-venous medication preparation, compounding, and dispensing Robots, providing healthcare facilities in four continents with robotics technology and software automation solutions. The world-leading solutions CytoCare [hazardous IVs], i.v.STATION [non-hazardous IVs], i.v.SOFT [workflow engine] and the future development of TPNstation, have and will greatly contribute to ease global hospitals’ growing pressures to improve patient safety through the effective and efficient production of sterile, accurate, and ready-to-administer IVs, to eliminate life-threatening drug-exchange errors, to decrease other medication errors and sterility risks, and to work more efficiently, increase throughput, reduce waste, and contain costs. For more information, please visit www.health-robotics.com

About Double Success Co. Ltd.:

Founded in 1974 by the venerable Mr. Robert Lee, Double Success generates an annual turnover well in excess of NT$ 400 million, including its EAL Medical Supplies subsidiary established in 1993, with offices in Taipei, Taichung, and Kaohsiung, including 18 sales representatives and 22 logistic staff. Double Success is Taiwan’s exclusive distributor for Intuitive Surgical’s daVinci Surgery Robot, Cardinal Health’s Snowden-Pencer Endoscopic Video System and Instrumentation, Applied Medical Resource’s Laparoscopic Access System and Endourology Products, Microtek’s Sterile Drape Products, Burnishine’s Instrumentation Care Products, Mentor-Byron Medical - Lysonix’s Ultrasonic Surgical System, Simbionix’s Skill Center Computerized Simulator, and Starion Instruments’s Thermal Welding System.

For additional information, please contact: Health Robotics S.r.l Gaspar G. DeViedma, General Counsel Altmanstrasse 9A, Bozen, Sud-Tyrol, Italy-39100 USA: +1-609-980-7976 EUROPE: +39-346-963-4934 gaspar.deviedma@health-robotics.com Double Success Eddy Liu, General Manager 1F,16-1,24 Lane,Chin-Men St., Taipei 100, Taiwan Taiwan: +866-2-23654222

Source: Health Robotics

For additional information, please contact: Health Robotics S.r.l, Gaspar G. DeViedma, General Counsel, Altmanstrasse 9A, Bozen, Sud-Tyrol, Italy-39100, USA: +1-609-980-7976, EUROPE: +39-346-963-4934, gaspar.deviedma at health-robotics.com; Double Success, Eddy Liu, General Manager, 1F, 16-1, 24 Lane, Chin-Men St., Taipei 100, Taiwan, Taiwan: +866-2-23654222